1. Home
  2. CPIX vs ANEB Comparison

CPIX vs ANEB Comparison

Compare CPIX & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • ANEB
  • Stock Information
  • Founded
  • CPIX 1999
  • ANEB 2020
  • Country
  • CPIX United States
  • ANEB United States
  • Employees
  • CPIX N/A
  • ANEB N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPIX Health Care
  • ANEB Health Care
  • Exchange
  • CPIX Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • CPIX 35.4M
  • ANEB 36.7M
  • IPO Year
  • CPIX 2009
  • ANEB 2021
  • Fundamental
  • Price
  • CPIX $4.64
  • ANEB $1.57
  • Analyst Decision
  • CPIX
  • ANEB Buy
  • Analyst Count
  • CPIX 0
  • ANEB 1
  • Target Price
  • CPIX N/A
  • ANEB $8.00
  • AVG Volume (30 Days)
  • CPIX 4.5M
  • ANEB 13.4K
  • Earning Date
  • CPIX 03-04-2025
  • ANEB 02-11-2025
  • Dividend Yield
  • CPIX N/A
  • ANEB N/A
  • EPS Growth
  • CPIX N/A
  • ANEB N/A
  • EPS
  • CPIX N/A
  • ANEB N/A
  • Revenue
  • CPIX $36,785,442.00
  • ANEB N/A
  • Revenue This Year
  • CPIX N/A
  • ANEB N/A
  • Revenue Next Year
  • CPIX N/A
  • ANEB N/A
  • P/E Ratio
  • CPIX N/A
  • ANEB N/A
  • Revenue Growth
  • CPIX N/A
  • ANEB N/A
  • 52 Week Low
  • CPIX $1.04
  • ANEB $0.80
  • 52 Week High
  • CPIX $6.43
  • ANEB $3.30
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 83.81
  • ANEB 50.97
  • Support Level
  • CPIX $2.08
  • ANEB $1.45
  • Resistance Level
  • CPIX $6.43
  • ANEB $1.72
  • Average True Range (ATR)
  • CPIX 0.53
  • ANEB 0.14
  • MACD
  • CPIX 0.27
  • ANEB -0.00
  • Stochastic Oscillator
  • CPIX 74.94
  • ANEB 50.14

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Share on Social Networks: